IP Verse

Functional Antibody Fragment Complementation For A Two Components System For Redirected Killing Of Unwanted Cells - EP3377103

PATENT ANALYSIS

Patent Details

Grant Date
Mar 17, 2021
Company
REVITOPE LIMITED
Oppositions

CHERRY BIOLABS GMBH

TAKEDA PHARMACEUTICAL COMPANY LIMITED

More patents of Revitope Limited

EP3377103

Want to monitor this patent?

Feel free to send us a message here and we will get back to you